NSK Ltd. - NPSKY

NPSKY Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
NPSKY	4.0	-1.1	8.6	-0.3	-14.1	-19.3	-33.8	-53.4	-62.6	42.4
S&P 500	1.0	0.6	1.1	2.4	8.9	23.6	36.4	80.6	195.1	33856.2

Compare NPSKY with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	NPSKY
name	NSK Ltd.
price	8.76
changes percentage	4.038
change	0.34
day low	8.46
day high	8.76
year high	11.84
year low	7.87
market cap	2140917606
price avg 50	8.7578
price avg 200	9.77865
exchange	PNK
volume	300
avg volume	477
open	8.46
previous close	8.42
eps	0.3
pe	29.2
earnings announcement	2025-01-31T06:00:00.000+0000
shares outstanding	488793975
timestamp	2025-01-17 20:53:03

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 50.7%

Overall Quarterly Financial Health: 45.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
revenue	788867000000	938098000000	-15.91
gross profit	165249000000	191065000000	-13.51
gross profit ratio	0.21	0.2	2.85
research and development expenses	15602000000	19839000000	-21.36
operating expenses	140921000000	161324000000	-12.65
interest income	2301000000	2369000000	-2.87
interest expense	2855000000	3380000000	-15.53
ebitda	78794000000	91137000000	-13.54
ebitdaratio	0.1	0.1	0.02
operating income	24328000000	32936000000	-26.14
operating income ratio	0.03	0.04	-12.16
net income	8503000000	18412000000	-53.82
net income ratio	0.01	0.02	-45.08
eps	26.69	35.89	-25.63

Overall Score of Annual Income Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 788,867 million in 2024 from 938,098 million in 2023 representing a change of -15.91%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 165,249 million in 2024 from 191,065 million in 2023 representing a change of -13.51%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 15,602 million in 2024 from 19,839 million in 2023 representing a change of -21.36%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 78,794 million in 2024 from 91,137 million in 2023 representing a change of -13.54%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 24,328 million in 2024 from 32,936 million in 2023 representing a change of -26.14%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Earnings per Share (EPS): EPS increased to 26.69 in 2024 from 26.69 in 2023 representing a change of -25.63%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 140,921 million in 2024 from 161,324 million in 2023 representing a change of -12.65%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Net Income: Net income increased to 8,503 million in 2024 from 18,412 million in 2023 representing a change of -53.82%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
revenue	200495000000	200808000000	-0.16
gross profit	43257000000	40866000000	5.85
gross profit ratio	0.22	0.2	6.02
research and development expenses	0	4135000000	-100.00
operating expenses	37384000000	35517000000	5.26
interest income	914000000	770000000	18.70
interest expense	1633000000	1285000000	27.08
ebitda	19236000000	20520000000	-6.26
ebitdaratio	0.1	0.09	2.11
operating income	5873000000	5349000000	9.80
operating income ratio	0.03	0.03	9.97
net income	1902000000	3780000000	-49.68
net income ratio	0.01	0.02	-49.60
eps	4.22	7.74	-45.48

Overall Score of Quarterly Income Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 200,495 million in 2025Q1 from 200,808 million in 2024Q4 representing a change of -0.16%. This indicates a sales shrinking, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2025Q1 from 4,135 million in 2024Q4 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 37,384 million in 2025Q1 from 35,517 million in 2024Q4 representing a change of 5.26%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 19,236 million in 2025Q1 from 20,520 million in 2024Q4 representing a change of -6.26%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to 1,902 million in 2025Q1 from 3,780 million in 2024Q4 representing a change of -49.68%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 4.22 in 2025Q1 from 4.22 in 2024Q4 representing a change of -45.48%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 43,257 million in 2025Q1 from 40,866 million in 2024Q4 representing a change of 5.85%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Income: Operating income increased to 5,873 million in 2025Q1 from 5,349 million in 2024Q4 representing a change of 9.8%. The increase in operating income indicates better operational performance and increased profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
total assets	1298077000000	1233256000000	5.26
total liabilities	620123000000	598532000000	3.61
total equity	677954000000	634724000000	6.81
cash and cash equivalents	150583000000	160109000000	-5.95
short term investments	45076000000	1590000000	2734.97
long term investments	229647000000	195468000000	17.49
total current assets	636623000000	587656000000	8.33
total non current assets	661454000000	645600000000	2.46
total current liabilities	347775000000	307348000000	13.15
total non current liabilities	260978000000	291184000000	-10.37
common stock	67176000000	67176000000	0.00
retained earnings	375402000000	415736000000	-9.70
total debt	342613000000	360814000000	-5.04

Overall Score of Annual Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,298,077 million in 2024 from 1,233,256 million in 2023 representing a change of 5.26%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 677,954 million in 2024 from 634,724 million in 2023 representing a change of 6.81%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 45,076 million in 2024 from 1,590 million in 2023 representing a change of 2734.97%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 636,623 million in 2024 from 587,656 million in 2023 representing a change of 8.33%. This indicates a better liquidity position.

  Total Debt: Total Debt decreased to 342,613 million in 2024 from 360,814 million in 2023 representing a change of -5.04%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 620,123 million in 2024 from 598,532 million in 2023 representing a change of 3.61%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 150,583 million in 2024 from 160,109 million in 2023 representing a change of -5.95%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 347,775 million in 2024 from 307,348 million in 2023 representing a change of 13.15%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 375,402 million in 2024 from 415,736 million in 2023 representing a change of -9.7%. This indicates an accumulated losses.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
total assets	1301184000000	1298077000000	0.24
total liabilities	607388000000	620120000000	-2.05
total equity	693796000000	677954000000	2.34
cash and cash equivalents	154595000000	150583000000	2.66
short term investments	28806000000	41404000000	-30.43
long term investments	103742000000	101537000000	2.17
total current assets	633167000000	636623000000	-0.54
total non current assets	668017000000	661454000000	0.99
total current liabilities	347940000000	359145000000	-3.12
total non current liabilities	259448000000	260975000000	-0.59
common stock	67176000000	67176000000	0.00
retained earnings	370060000000	375402000000	-1.42
total debt	0	342613000000	-100.00

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,301,184 million in 2025Q1 from 1,298,077 million in 2024Q4 representing a change of 0.24%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 607,388 million in 2025Q1 from 620,120 million in 2024Q4 representing a change of -2.05%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 693,796 million in 2025Q1 from 677,954 million in 2024Q4 representing a change of 2.34%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 154,595 million in 2025Q1 from 150,583 million in 2024Q4 representing a change of 2.66%. This indicates an increase in available liquid assets.

  Total Current Liabilities: Total Current Liabilities decreased to 347,940 million in 2025Q1 from 359,145 million in 2024Q4 representing a change of -3.12%. This indicates a lower short-term debt burden.

  Total Debt: Total Debt decreased to 0 million in 2025Q1 from 342,613 million in 2024Q4 representing a change of -100.0%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Short Term Investments: Short Term Investments decreased to 28,806 million in 2025Q1 from 41,404 million in 2024Q4 representing a change of -30.43%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 633,167 million in 2025Q1 from 636,623 million in 2024Q4 representing a change of -0.54%. This indicates a worsen liquidity position.

  Retained Earnings: Retained Earnings decreased to 370,060 million in 2025Q1 from 375,402 million in 2024Q4 representing a change of -1.42%. This indicates an accumulated losses.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
net change in cash	-9526000000	22605000000	-142.14
operating cash flow	99818000000	64163000000	55.57
free cash flow	41121000000	12414000000	231.25
capital expenditure	-58697000000	-51749000000	-13.43
depreciation and amortization	54121000000	58376000000	-7.29
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	12235000000	-10130000000	220.78
inventory	4016000000	6330000000	-36.56
acquisitions net	-10917000000	-7155000000	-52.58
investments in property plant and equipment	-49933000000	-51749000000	3.51
net cash used for investing activites	-90814000000	-48778000000	-86.18
debt repayment	18429000000	26908000000	-31.51
common stock issued	0	0	NaN
common stock repurchased	-21717000000	-1000000	-2171600.00
dividends paid	-15037000000	-15386000000	2.27
net cash used provided by financing activities	-24780000000	4417000000	-661.01
cash at end of period	150583000000	160109000000	-5.95
accounts receivables	4816000000	5100000000	-5.57
cash at beginning of period	160109000000	137504000000	16.44

Overall Score of Annual Cashflow Statement

0.71 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -9,526 million in 2024 from 22,605 million in 2023 representing a change of -142.14%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Accounts Payables: The absolute value of Accounts Payables increased to 12,235 million in 2024 from 10,130 million in 2023 representing a change of 220.78%. This indicates that the company has increased its outstanding obligations to its suppliers.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 99,818 million in 2024 from 64,163 million in 2023 representing a change of 55.57%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 41,121 million in 2024 from 12,414 million in 2023 representing a change of 231.25%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -58,697 million in 2024 from -51,749 million in 2023 representing a change of -13.43%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to 4,816 million in 2024 from 5,100 million in 2023 representing a change of -5.57%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -15,037 million in 2024 from -15,386 million in 2023 representing a change of 2.27%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
operating cash flow	9697000000	10575000000	-8.30
free cash flow	-1877000000	-4097000000	54.19
capital expenditure	-11574000000	-14672000000	21.12
depreciation and amortization	13594000000	13518000000	0.56
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	11479000000	-3290000000	448.91
accounts payables	-760000000	-8083000000	90.60
inventory	-2189000000	4437000000	-149.34
acquisitions net	0	297000000	-100.00
investments in property plant and equipment	-11574000000	-14672000000	21.12
net cash used for investing activites	3631000000	-8535000000	142.54
debt repayment	-5483000000	-16110000000	65.97
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-7251000000	-29000000	-24903.45
net cash used provided by financing activities	-12612000000	-17682000000	28.67
net change in cash	154595000000	-12479000000	1338.84
cash at end of period	154595000000	150583000000	2.66
cash at beginning of period	0	163062000000	-100.00

Overall Score of Quarterly Cashflow Statement

0.43 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 154,595 million in 2025Q1 from -12,479 million in 2024Q4 representing a change of 1338.84%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Free Cash Flow: Free Cash Flow increased to -1,877 million in 2025Q1 from -4,097 million in 2024Q4 representing a change of 54.19%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 760 million in 2025Q1 from 8,083 million in 2024Q4 representing a change of 90.6%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 9,697 million in 2025Q1 from 10,575 million in 2024Q4 representing a change of -8.3%. This indicates that the company generated less cash from its core business operations.

  Capital Expenditure: Capital Expenditure increased to -11,574 million in 2025Q1 from -14,672 million in 2024Q4 representing a change of 21.12%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to 11,479 in 2025Q1 from -3,290 million in 2024Q4 representing a change of 448.91%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -7,251 million in 2025Q1 from -29 million in 2024Q4 representing a change of -24903.45%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-03-31	2023-03-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	1595.92	1828.55	-12.72
net income per share	17.2	35.89	-52.07
operating cash flow per share	201.94	125.07	61.46
free cash flow per share	83.19	24.2	243.80
cash per share	395.83	315.18	25.59
book value per share	1371.54	1237.21	10.86
tangible book value per share	1257.14	1141.26	10.15
shareholders equity per share	1335.17	1201.13	11.16
interest debt per share	698.9	709.89	-1.55
market cap	433157127397.5	387849924000	11.68
enterprise value	625187127397.5	588554924000	6.22
pe ratio	50.95	21.07	141.86
price to sales ratio	0.55	0.41	32.81
pocfratio	4.34	6.04	-28.21
pfcf ratio	10.53	31.24	-66.28
pb ratio	0.66	0.63	4.28
ptb ratio	0.66	0.63	4.28
ev to sales	0.79	0.63	26.32
enterprise value over ebitda	7.74	6.46	19.86
ev to operating cash flow	6.26	9.17	-31.72
ev to free cash flow	15.2	47.41	-67.93
earnings yield	0.02	0.05	-58.65
free cash flow yield	0.09	0.03	196.60
debt to equity	0.52	0.59	-11.34
debt to assets	0.26	0.29	-9.79
net debt to ebitda	2.38	2.2	7.96
current ratio	1.77	1.91	-7.29
interest coverage	8.52	9.74	-12.55
income quality	4.3	2.01	113.86
dividend yield	0.03	0.04	-12.49
payout ratio	1.77	0.84	111.65
sales general and administrative to revenue	0.12	0.17	-29.63
research and ddevelopement to revenue	0.02	0.02	-6.48
intangibles to total assets	0.04	0.04	9.14
capex to operating cash flow	0.59	0.81	-27.09
capex to revenue	0.07	0.06	34.88
capex to depreciation	1.08	0.89	22.34
stock based compensation to revenue	0	0	NaN
graham number	718.83	984.84	-27.01
roic	0.01	0.02	-50.40
return on tangible assets	0.01	0.02	-55.96
graham net net	-336.5	-354.94	5.20
working capital	277478000000	280308000000	-1.01
tangible asset value	621406000000	585497000000	6.13
net current asset value	16500000000	-10876000000	251.71
invested capital	698973000000	715148000000	-2.26
average receivables	214030000000	208581500000	2.61
average payables	101365500000	98714000000	2.69
average inventory	191820000000	197245000000	-2.75
days sales outstanding	101.91	80.86	26.03
days payables outstanding	62.66	46.22	35.56
days of inventory on hand	107.72	96.62	11.49
receivables turnover	3.58	4.51	-20.66
payables turnover	5.82	7.9	-26.23
inventory turnover	3.39	3.78	-10.31
roe	0.01	0.03	-56.89
capex per share	118.75	100.87	17.72

• Negative

  ROE: Return on Equity (ROE) decreased to 0.01 on 2024-03-31 from 0.03 on 2023-03-31, representing a change of -56.89%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 50.95 on 2024-03-31 from 21.07 on 2023-03-31, representing a change of 141.86%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.52 on 2024-03-31 from 0.59 on 2023-03-31, representing a change of -11.34%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 1.77 on 2024-03-31 from 1.91 on 2023-03-31, representing a change of -7.29%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Quarterly Financial Ratios

	2024-09-30 Q2	2024-06-30 Q1	Q/Q change %
NPSKY
calendar year	2024	2024	NaN
revenue per share	403.34	426.42	-5.41
net income per share	0.14	4.05	-96.61
operating cash flow per share	-8.63	20.62	-141.85
free cash flow per share	-29.38	-3.99	-636.02
cash per share	290.66	390.06	-25.48
book value per share	1350.39	1475.59	-8.48
tangible book value per share	1230.21	1348.14	-8.75
shareholders equity per share	1314.75	1438.52	-8.60
interest debt per share	3.64	453.42	-99.20
market cap	352371948561.9	373325066182	-5.61
enterprise value	210300948561.9	430285066182	-51.13
pe ratio	1314.82	49.07	2579.48
price to sales ratio	1.79	1.86	-4.01
pocfratio	-83.52	38.5	-316.94
pfcf ratio	-24.54	-198.89	87.66
pb ratio	0.55	0.55	-0.66
ptb ratio	0.55	0.55	-0.66
ev to sales	1.07	2.15	-50.30
enterprise value over ebitda	11.78	22.37	-47.35
ev to operating cash flow	-49.85	44.37	-212.33
ev to free cash flow	-14.64	-229.24	93.61
earnings yield	0.0	0.01	-96.27
free cash flow yield	-0.04	-0.01	-710.66
debt to equity	0	0.31	-100.00
debt to assets	0	0.16	-100.00
net debt to ebitda	-7.96	2.96	-368.70
current ratio	2.04	1.82	12.26
interest coverage	3.89	3.6	8.28
income quality	-2.25	5.1	-144.06
dividend yield	0.0	0.02	-98.79
payout ratio	1.24	3.81	-67.51
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.04	0.08	-55.41
intangibles to total assets	0.05	0.05	4.51
capex to operating cash flow	-2.4	1.19	-301.42
capex to revenue	0.05	0.06	-10.88
capex to depreciation	0.77	0.85	-9.09
stock based compensation to revenue	0	0	NaN
graham number	63.68	361.84	-82.40
roic	0.01	0.0	135.05
return on tangible assets	0.0	0.0	-96.24
graham net net	-346.97	-344.87	-0.61
working capital	296873000000	285227000000	4.08
tangible asset value	601318000000	633870000000	-5.14
net current asset value	21085000000	25779000000	-18.21
invested capital	701240000000	710049000000	-1.24
average receivables	214293000000	220051000000	-2.62
average payables	128051000000	139351500000	-8.11
average inventory	189171500000	189885500000	-0.38
days sales outstanding	95.29	98.69	-3.45
days payables outstanding	68.56	79.13	-13.36
days of inventory on hand	107.31	110.98	-3.30
receivables turnover	0.94	0.91	3.57
payables turnover	1.31	1.14	15.42
inventory turnover	0.84	0.81	3.41
roe	0.0	0.0	-96.29
capex per share	20.75	24.62	-15.70

• Negative

  ROE: Return on Equity (ROE) decreased to 0.00 on 2024-09-30 Q2 from 0.00 on 2024-06-30 Q1, representing a change of -96.29%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 1314.82 on 2024-09-30 Q2 from 49.07 on 2024-06-30 Q1, representing a change of 2579.48%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 2.04 on 2024-09-30 Q2 from 1.82 on 2024-06-30 Q1, representing a change of 12.26%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2024-09-30 Q2 from 0.31 on 2024-06-30 Q1, representing a change of -100.00%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 9.09 which is higher than current price 8.76, indicates the company may be undervalued.